Sutro Biopharma Stock (NASDAQ:STRO), Quotes and News Summary

Q: What sector and industry does Sutro Biopharma (STRO) operate in?

Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Sutro Biopharma Stock (NASDAQ: STRO) stock price, news, charts, stock research, profile.

Open	$4.000
Close	$4.150
Volume / Avg.	578.656K / 984.531K
Day Range	3.930 - 4.170
52 Wk Range	2.005 - 6.130
Market Cap	$327.876M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	2.4%
Days to Cover	3.18

Recent News

What's Going On With Sutro Biopharma (STRO) Stock?

Sutro Biopharma shares are trading lower by 4.3% during Tuesday's session. The company announced the pricing of an underwritten offering.

Henry Khederian

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

Avi Kapoor

REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat quarterly earnings.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Sutro Biopharma (STRO) stock?

You can purchase shares of Sutro Biopharma (NASDAQ: STRO) through any online brokerage.

View our list of the best stock brokerages.

Who are Sutro Biopharma's (STRO) competitors?

Other companies in Sutro Biopharma’s space includes: Macrogenics (NASDAQ:MGNX), Skye Bioscience (NASDAQ:SKYE), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).

What is the target price for Sutro Biopharma (STRO) stock?

The latest price target for Sutro Biopharma (NASDAQ: STRO) was reported by Oppenheimer on Wednesday, May 15, 2024. The analyst firm set a price target for 10.00 expecting STRO to rise to within 12 months (a possible 149.38% upside). 24 analyst firms have reported ratings in the last year.

Current Stock Price for Sutro Biopharma (STRO)?

The stock price for Sutro Biopharma (NASDAQ: STRO) is $4.01 last updated May 16, 2024 at 8:56 AM EDT.

Does Sutro Biopharma (STRO) pay a dividend?

There are no upcoming dividends for Sutro Biopharma.

When is Sutro Biopharma (NASDAQ:STRO) reporting earnings?

Sutro Biopharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Sutro Biopharma (STRO) going to split?

There is no upcoming split for Sutro Biopharma.

What sector and industry does Sutro Biopharma (STRO) operate in?

Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-